MARCIO LICURGO DE AZEVEDO: Open Payments
NPI 1861266074 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 20 payments from 7 companies in 2025. Trend: 2023 $196 · 2024 $1,771 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $260 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, HETLIOZ, Auvelity, COBENFY, LYBALVI.
Industry payments across FL — which companies pay providers there.
